Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Triple digits revenue potential. Don’t get scared. Know what you own here.
Large hospital health system. For covid we use the abbot id now, biofire respiratory viral panels, and Cepheid gene expert 4 plex test.
Well, the machine that T2 uses to run their COVID and the fungal sepsis test on doesn’t work that well and is rather complicated to use. Our laboratory was never able to validate the covid test even after having their people come out multiple times to try to get it to work. Interesting movement in the stock, but I’m not specifically a believer in them that’s all. Power to you all if you’re banking on these moves though. I like to see others making bank.
Beginning
Maybe he will. Never know. They’re going to eventually have to start addressing investors more. I’ve been very pleased with my returns here but I believe this can really break out higher
Bought a few thousand today here. See what happens
Full send here today. Hell yeah. One of my best short term trades. Kept some free shares to ride to the end. Lot of potential for this to continue to multiple triple digits
Revenue potential here is still 2-3 billion plus dollars this year if all comes together as planned. That’s about the market cap where it’s at $18 a share. So what will it trade at? 10-20x earning? Still potential for triple digits coming here
HC wainwright- same guys who did the direct offering at $7+ over the weekend? I swear analysts are all just full of crap and say whatever while actually they’re loading the boat to sell to others higher. $4.50 give me a break lol
Wouldn’t mess with it yet because this thing does look like it’s heading for the sky. But this companies product isn’t that great. We can’t even get their analyzer validated to run the COVID tests in my laboratory. They’ve been out multiple times and can’t figure out what’s wrong.
Me too. This things ready to explode
Been really nice since announcing that $100+ million dollar deal last month. Prob something more going on here now. Expect news soon
Nice movement here lately. Push for $10+ coming?
Already exists doesn’t it? Everest medicine ..... should have an update on that anytime.
Also interesting it had such a large volume of shorts on that spike on the news on Jan 12th. Yet it’s held gains and is going back up on relatively low volume. Could squeeze them
Tang prob buying more today
Swing and a miss on that assessment?
LJPC is next. Follow the money
Yeah I don’t disagree. Public company’s are supposed to be more transparent than this. But I’m sure there’s something big in the works behind the curtains here and it will be revealed, eventually.
I honestly don’t care how transparent they are. I’m sure they’ll share news when they have it. No way Tang is putting that much on the line and buying up the float for nothing. Something is up here for sure.
$LJPC - tons of insider buying. Price breaking out now. News imminent
$LJPC
Has to be something good in the works here with all this insider buying. The tetraphase buyout looks promising as well. Interesting news with them letting the contract for their facility expire. Could be a buyout or something else like a merger etc. I’m in this heavily, I see too much potential.
Kevin Tang owns what now like 35-40% of this company? And he keeps buying
Look at these idiots..... lot of stories like this out there. Take another hit and come up with some more good ideas Elon!
https://www.wired.com/story/elon-musk-weed-toke-tesla/
Several promising known drugs stand out as potential inhibitors of SARS-Cov-2 main protease, including Carfilzomib, Eravacycline, Valrubicin, Lopinavir and Elbasvir. Carfilzomib, an approved anti-cancer drug acting as a proteasome inhibitor, has the best MM-PBSA-WSAS binding free energy, -13.8 kcal/mol. The second-best repurposing drug candidate, eravacycline, is synthetic halogenated tetracycline class antibiotic.
https://pubs.acs.org/doi/10.1021/acs.jcim.0c00179
Several promising known drugs stand out as potential inhibitors of SARS-Cov-2 main protease, including Carfilzomib, Eravacycline, Valrubicin, Lopinavir and Elbasvir. Carfilzomib, an approved anti-cancer drug acting as a proteasome inhibitor, has the best MM-PBSA-WSAS binding free energy, -13.8 kcal/mol. The second-best repurposing drug candidate, eravacycline, is synthetic halogenated tetracycline class antibiotic.
https://pubs.acs.org/doi/10.1021/acs.jcim.0c00179
TTPH merging with acrx - 1 share of ttph gives .63 shares of acrx. That being said, ttph and acrx are almost trading at the same price right now. That makes no sense ??
Yeah I just was unsure what was happening. Seemed every single stock was going up in aftermarket (thus FAZ tanked). It seems it was trumps we are opening back up speech. But still the same reasons that the financial industry is going to be doing poorly in coming months has not changed.
Why is FAZ tanking right now?
Company says they “validated” a molecular based covid test ...... for all we know they bought an idnow from Abbott and are using that to test. What reason does them offering those tests justify this jump in share price?
Yes - this is the company that owns Cepheid and their testing platform genexpert is in almost any hospital and WILL be what most hospitals use for the testing for covid19 in house. Biomerieux is another company that has the bio fire test that will likely be approved soon as well. Almost everyone uses that platform as well and it would be even more likely to be used as they have a panel test that could test for this strain of Coronavirus as well as many other viruses that could cause illnesses all at once.
Another new investment back initiated coverage and has price targets of over 100% higher than where we're currently trading. That's 2 in a weeks time now.
HC Wainwright on 2/6/18 price target $17
Today 2/12/18 B Riley FBR price targrt $11
Lets get that good cUTI data out there already
Yes it does
If this was just tetraphase I would be worried. But its the whole market. It is what it is. Nothing has changed from my views about this company.
Wow, what a crazy trading day. I damn near got shook out.
No, but in hindsight that would have been a good idea that I will use in the future. It was only like the first 5 mins this morning when the market opened. There were trades going through as it was dropping and the bid was showing below $5 but trades were going through at low $5's all while the ask was stitting not moving at $5.18. I tried a couple times with various bids and eventually got filled with a limit at $5.15. May have just been connection problems on my end too who knows.
Interesting perspective. I would love for them to be trying to flush out retail before a move up. That would be best case senairo for this drop into the $5's before good data. I was trying to buy and couldn't figure out where to put in a bid because the bid kept changing although the trades were not going through at either the bid or the ask price. Very unusual. I was able to buy some at $5.15 ..... but the bid was flashing between $3.44 and $4.8 and wasn't even showing in the $5's. That could potentially have scared someone into selling I guess.
Just using etrade though my phone.
Maybe they dilute immediatly maybe not. But these results will be a significant material event for this company that should increase the value significantly. And new trials for oral will start again too which should add even more value.